Bcl-2, one of a family of key regulators of apoptosis, was the first cell-death machinery component to be identified, but how the family functions is still not clear. Mammalian Bax, a pro-apoptotic family member, can cause yeast cells to die, and two recent yeast genetic screens shed light on how Bax might function.
Figure 1
The relative positions of the conserved domains in Bcl-x L , the only Bcl-2 family member for which the crystal structure is known. BH1, khaki; BH2, yellow; BH3, orange. (a) A schematic of the Bcl-x L protein structure, and an alignment of the BH domains from Bcl-x L , Bcl-2, Bax and Bak. Deletions that did not abolish the cytotoxic activity of Bax in yeast are boxed in black; deletions that did abolish the cytotoxicity of Bax and Bak in yeast are boxed in red. Positions of the alpha helices are shown as pink boxes. MA, membrane attachment region; Loop, unstructured loop domain that is not present in all Bcl-2 family members. (b) Space-filling model of Bcl-x L binding to the Bak BH3 peptide. The Bak peptide is shown as a purple helix (using coordinates from [3] ). (c) Bcl-x L structure [2] with helix 5, bright red and helix 6, paler red; also highlighted is part of BH2 (yellow) and the whole of BH3 (orange).
(d)
The same Bcl-x L structure [2] but showing in gray the conserved amino acids from Bcl-x L which, when deleted from Bax, did not abolish cytotoxic activity of Bax in yeast (as boxed in black in (a)); and in red the conserved amino acids from Bcl-x L which, when deleted from Bax, abolished the cytotoxicity of Bax in yeast (as boxed in red in (a)). All images were generated with RasMol2.6 [22] . Note that all images show only the crystal structure of Bclx L , and this structure can only be used to make inferences about that of Bax or Bak. 
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Hrk and Bim -have only a BH3 domain in common with the rest of the Bcl-2 family. Some of the anti-apoptotic homologs also have a BH4 region, which is essential both for their pro-survival function and to allow them, when overexpressed in mammalian cells, to interact (directly or indirectly) with the Caenorhabditis elegans protein Ced-4, an adaptor that activates the caspases [5] .
Several mechanisms of action have been proposed for the pro-and anti-apoptotic Bcl-2 family members. From genetic studies in C. elegans, it seems that Ced-9, the nematode Bcl-2 homolog, functions to prevent the adaptor Ced-4 from activating the caspase Ced-3. Biochemical data suggest the interactions between Ced-9, Ced-4 and Ced-3 are direct, and analogous direct interactions occur in mammalian systems to allow Bcl-x L to bind the Ced-4 homolog Apaf-1 and prevent it from activating pro-caspase 9 ( Figure 2 ).
The crystal structure of the anti-apoptotic Bcl-x L revealed that Bcl-x L shares a common fold with certain poreforming molecules, including the membrane-translocating subunit of diphtheria toxin [2] . This led to speculation that proteins of the Bcl-2 family might act as pores or channels in membranes such as the outer membrane of the mitochondrion, where around one third of the cell's Bcl-2 is located. Subsequent studies have shown that Bax has poreforming potential in vitro that can be inhibited by Bcl-2 [6] .
Biochemical purification of Apaf-1 revealed that cytochrome c is a molecule capable of activating a complex of Apaf-1, dATP and pro-caspase 9. This finding led to the proposal that Bcl-2 and Bcl-x L act by preventing the release of cytochrome c from the mitochondria [7] , while Bax promotes cytochrome c release, leading to apoptosis ( Figure 2 ) [8] . But this model does not explain why Bcl-2 targeted to the endoplasmic reticulum is still able to prevent apoptosis, nor why Bcl-2 can protect cells even after cytochrome c has entered the cytoplasm [8, 9] .
Whatever the precise mechanism of action of Bcl-2 and Bcl-x L , the simplest model for Bax function is that Bax binds to and antagonises Bcl-2 and Bcl-x L . An alternative proposal is that pro-apoptotic Bcl-2 family proteins, such as Bax and Bak, actively participate in the cell-killing process but act through a caspase-independent mechanism. This model stemmed from an observation that, at least in one circumstance, Bax cytotoxicity in mammalian cells was not inhibited by peptide inhibitors of caspase activity [10] , and observations that Bax or Bak was toxic when expressed in the yeasts Saccharomyces cerevisiae [11, 12] or Schizosaccharomyces pombe [13] , even though neither organism appears to contain a caspase.
The ability of Bax to kill yeast cells is significant for two reasons: firstly, it allows Bax to be studied in cells that lack caspases and other Bcl-2 family members, and secondly, it allows the use of a genetic approach to determine Bax function. Two recent publications (discussed below) support the idea that Bax can kill independent of caspases and other Bcl-2 family members. The key questions are how Bax kills yeast cells, and whether or not Bax behaves in yeast the same way it does in mammalian cells. Bax might kill yeast via some activity that is not related to its function in mammalian cells. For example, while overexpression of the c-Src protein-tyrosine kinase transforms mammalian cells, S. pombe expressing c-Src die, presumably as a result of the inappropriate massive phosphorylation of tyrosines in yeast proteins [14] .
Alternatively yeast-cell killing might reflect Bax acting by targeting similar molecules in both yeast and mammalian cells. Thus, for example, expression of the chimeric activator GAL4-VP16 is toxic to S. cerevisiae [15] : this chimeric protein is such a potent activator of transcription that it is able squelch yeast co-activators of transcription that are necessary for survival. In a similar way, Bax might bind to some conserved element which underlies its cytotoxic activity in both yeast and mammalian cells. This explanation would be consistent with the one proven molecular aspect of Bax function, which is that it binds to other proteins.
In some ways, Bax killing of yeast cells resembles Baxinduced apoptosis of mammalian cells. As in mammalian cells, Bax can associate with the mitochondria, and this localisation requires its carboxy-terminal hydrophobic tail in yeast. In both mammalian and yeast cells, Bax causes release of cytochrome c from mitochondria [16] , and coexpression of Bcl-2 prevents Bax-induced killing. It should be emphasised that the ability of Bcl-2 to protect does not necessarily mean that Bax killing of yeast is physiological, however, as Bcl-2 co-expression might protect yeast by being a preferred partner for Bax, thereby preventing a non-physiological cytotoxic activity. In other ways Bax behaves differently in the two systems. Bax probably only localises to mitochondria following a death stimulus in mammalian cells [17] , whereas it appears to localise constitutively in yeast. Bax mutant proteins lacking the hydrophobic tail are not cytotoxic in yeast and do not localise to the mitochondria, whereas in mammalian cells Bax does not require the tail for cytotoxicity, possibly because it can be localised to the mitochondria during the induction of cell death by binding to other proteins.
As Bax has the potential to form pores in vitro, it is possible that pore formation kills yeast by allowing release of cytochrome c or by dissipation of the mitochondrial membrane potential. Arguing against this possibility, deletion of parts of the BH1 domain of Bax (Figure 1,  gray) , which would presumably significantly disrupt one of two central helices with membrane-spanning potential (Figure 1c ; helix 5, bright red, and helix 6, paler red), does not inhibit Bax's cytotoxicity in yeast [12] . The same is true for deletions within BH2, although these may not be so disruptive of the membrane-spanning helix. In striking contrast, a four amino-acid deletion within BH3 (Figure 1a,d, red) , which is clearly distinct from the membrane-spanning helices, completely abolishes the cytotoxic activity of Bax in both yeast and mammalian cells. Similar results were obtained with Bak ( Figure 1a ) [13] . These results imply that the BH3 domain of Bax, rather than the pore-forming region, is the key to its cytotoxicity in both yeast and mammalian cells. Of course, it remains entirely possible that the mutation in BH3 completely disrupts the structure, having indirect effects on the pore-forming region.
Do the results of genetic screens in yeast provide any further insight into Bax cytotoxicity? In the first screen [18] , the authors generated yeast mutants that were resistant to Bax killing. Sensitivity to Bax could be restored by co-expression of subunit 4 of the yeast F 0 F 1 ATPase (equivalent to subunit b of the animal mitochondrial F 0 F 1 ATPase) although, curiously, the actual mutation(s) in the resistant yeast strain was not reported [18] . Oligomycin, a pharmacological inhibitor of the F 0 F 1 ATPase, at the one concentration tested, conferred on wild-type yeast partial resistance to Bax expression, and yeast with a mutant δ subunit of the F 0 F 1 ATPase were completely resistant to Bax expression. As both subunits 4/b and δ are involved in joining the F 0 to the F 1 subunit, perhaps the F 0 F 1 connection is required for Bax to kill. These results were extended to mammalian cells by showing that, at an early time point, oligomycin quite effectively inhibited caspase activation and the induction of apoptotic morphology following Bax overexpression in 293 cells; and p53-induced apoptosis in baby rat kidney (BRK) cells was also delayed. These observations are curious on two levels. Firstly, why does oligomycin inhibit cell death induced by Bax if Baxinduced death results from Bcl-x L antagonism ( Figure 3 )? Do these results in mammalian cells mean that the function of the F 0 F 1 ATPase is required for Bax-Bcl-x L heterodimerisation, or that Bax-Bcl-x L heterodimerisation is not required for cell death? Secondly, p53-induced apoptosis occurs normally in the absence of Bax [19] , so why oligomycin has an effect on p53-induced apoptosis is unclear, although one might argue that pro-apoptotic family members other than Bax can kill by a similar route.
The other approach used was to co-express a mammalian cDNA library to look directly for suppressors of Bax killing in yeast [20] . This time, the authors found three independent clones for the cDNA that they termed Bax inhibitor 1 (BI-1), an evolutionarily conserved integral membrane protein containing six or seven membranespanning segments. How BI-1 was able to prevent yeast death was not determined, but, in transient transfection assays, BI-1 was also able to inhibit apoptosis of mammalian 293 cells induced by serum deprivation, the topoisomerase inhibitor etoposide and serine/threonine kinase inhibitor staurosporine. BI-1 appears to be associated with the endoplasmic reticulum membrane and the nuclear envelope. Although BI-1 does not bind to Bax, it is intriguing that it does bind to Bcl-2 in an interaction that requires the BH4 domain of Bcl-2. Although BI-1 might bind to Bcl-2 and thereby co-operate with it to inhibit Bax, it is difficult to envision how BI-1 operates in yeast, which lack Bcl-2.
Caution needs to be exercised in imagining how BI-1 might operate, however. The activities of BI-1 in mammalian cells are reminiscent of those of Bag-1, a molecule that was originally identified as a Bcl-2-interacting cell death inhibitor but has now been shown to be a regulator of Hsp70; Bag-1 probably only binds indirectly to Bcl-2 via Hsp70, and, furthermore, probably only binds to denatured Bcl-2 [21] . Interpretation of results from overexpression studies should take into account considerations such as protein folding and endoplasmic reticulum function before definitive answers about the way in which the normally expressed proteins protect cells can be gained.
Apoptosis research is a difficult business. The 'final readout' for the molecular players in the cell death program is either life or death, yet many non-physiological agents cause death, and many molecules which have no direct role in apoptosis might promote correct folding, processing or localisation of bona fide survival factors, conferring an apparent survival advantage. Whatever role is apportioned to the new players identified as a result of screening in yeast, we will certainly learn more from them about the life and death of cells.
